Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong · Delayed Price · Currency is HKD 2.450
+0.070 (2.94%)
Jun 1, 2026, 4:08 PM HKT
HKG:1349 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,666 | 7,469 | 6,602 | 8,057 | 7,767 | 13,434 | |
Market Cap Growth | -2.98% | 13.14% | -18.06% | 3.73% | -42.18% | -14.60% |
Enterprise Value | 5,391 | 6,265 | 5,465 | 6,850 | 6,427 | 12,106 |
Last Close Price | 2.38 | 2.78 | 2.44 | 2.39 | 3.16 | 3.42 |
PE Ratio | - | - | 156.13 | 67.32 | 49.79 | 51.31 |
Forward PE | - | 22.46 | 22.46 | 22.46 | 22.46 | 22.46 |
PS Ratio | 8.95 | 9.79 | 8.74 | 8.60 | 6.66 | 9.60 |
PB Ratio | 2.76 | 3.17 | 2.69 | 3.10 | 3.05 | 5.00 |
P/TBV Ratio | 2.84 | 3.27 | 2.78 | 3.22 | 3.13 | 5.20 |
P/FCF Ratio | 61.81 | 61.56 | - | - | 88.13 | 73.56 |
P/OCF Ratio | 45.87 | 47.47 | - | 102.98 | 41.57 | 40.70 |
PEG Ratio | - | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 |
EV/Sales Ratio | 7.24 | 8.21 | 7.24 | 7.31 | 5.51 | 8.65 |
EV/EBITDA Ratio | - | - | 87.73 | 48.18 | 30.41 | 45.55 |
EV/EBIT Ratio | - | - | - | 80.59 | 49.83 | 60.61 |
EV/FCF Ratio | 49.99 | 51.63 | - | - | 72.92 | 66.29 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.06 | 0.01 |
Debt / EBITDA Ratio | - | - | 0.31 | 0.13 | 0.64 | 0.14 |
Debt / FCF Ratio | 0.14 | 0.14 | - | - | 1.60 | 0.21 |
Net Debt / Equity Ratio | -0.53 | -0.53 | -0.45 | -0.50 | -0.53 | -0.54 |
Net Debt / EBITDA Ratio | 10.77 | 10.80 | -17.70 | -9.13 | -6.39 | -5.44 |
Net Debt / FCF Ratio | -11.82 | -10.39 | 17.50 | 42.17 | -15.32 | -7.91 |
Asset Turnover | 0.27 | 0.28 | 0.26 | 0.29 | 0.36 | 0.43 |
Inventory Turnover | 1.71 | 1.76 | 1.40 | 1.76 | 2.27 | 2.26 |
Quick Ratio | 7.24 | 5.88 | 6.09 | 3.60 | 2.98 | 3.56 |
Current Ratio | 7.46 | 6.05 | 6.40 | 3.70 | 3.07 | 3.65 |
Return on Equity (ROE) | -6.89% | -7.13% | 1.69% | 4.70% | 6.18% | 10.12% |
Return on Assets (ROA) | -4.01% | -4.01% | -0.18% | 1.65% | 2.48% | 3.85% |
Return on Invested Capital (ROIC) | -15.73% | -14.19% | -0.63% | 6.89% | 11.02% | 19.48% |
Return on Capital Employed (ROCE) | -7.30% | -7.50% | -0.30% | 3.30% | 5.00% | 7.20% |
Earnings Yield | -2.60% | -2.35% | 0.64% | 1.49% | 2.01% | 1.95% |
FCF Yield | 1.62% | 1.62% | -0.95% | -0.38% | 1.14% | 1.36% |
Dividend Yield | 1.35% | - | 2.18% | 3.23% | 2.50% | 2.51% |
Payout Ratio | - | - | 234.79% | 70.10% | 51.48% | 24.45% |
Buyback Yield / Dilution | - | - | -0.23% | -0.29% | 1.29% | -5.59% |
Total Shareholder Return | 1.35% | - | 1.95% | 2.94% | 3.80% | -3.08% |